InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.37
(
0.69%
)
US TECH 100
18,349.80
(
1.12%
)
Dow Jones
39,150.07
(
0.22%
)
Brent Oil
81.92
(
0.74%
)
Bitcoin
68,108.59
(
0.27%
)
Post# of 251930
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: rkrw post# 86175

Monday, 11/16/2009 1:59:03 AM

Monday, November 16, 2009 1:59:03 AM

Post# of 251930
Anyone following the Introgen story closely would say the same thing. They actually claimed in SEC filings they had a SPA on their Advexin trials. This was false, as I got them to admit on a conference call (the last call where they took my questions).

One more instance of the SEC and NASD asleep at the switch.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up